Skip to main
CTKB
CTKB logo

Cytek Biosciences (CTKB) Stock Forecast & Price Target

Cytek Biosciences (CTKB) Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 25%
Cytek Biosciences (CTKB) has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 25% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cytek Biosciences and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cytek Biosciences (CTKB) Forecast

Analysts have given Cytek Biosciences (CTKB) a Hold based on their latest research and market trends.

According to 4 analysts, Cytek Biosciences (CTKB) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cytek Biosciences (CTKB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.